Business
Bio Spectrum
"India has the talent and ambition to lead globally in advanced therapies, biologics, and oncology"
Thermo Fisher Scientific has recently announced plans to make significant investments in India's biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. Central to this expansion strategy are two major facilities in Genome Valley, Hyderabad, i.e. Bioprocess Design Center (BDC), and Customer Experience Center (CEC). In addition, the company has invested more than Rs 160 crore this year to expand its R&D facility in Bengaluru. For further understanding on these new developments, BioSpectrum spoke in detail to Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific. Edited excerpts;
4 min |
December 2025
Bio Spectrum
"AI is a transformative enabler that's reshaping how science is conducted in labs"
2025 witnessed multiple new initiatives taken by Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, for the Indian market. These initiatives included establishment of an India Solutions Center in Manesar; and a Biopharma Experience Center in Hyderabad. 2025 also saw Nandakumar Kalathil stepping in as the new Country General Manager for Agilent India. With over 25 years of experience in the analytical industry, Nanda brings extensive expertise in leadership, team management, and customer relations. To find out more about the company's growth plans in 2026 in India, BioSpectrum interacted with Nandakumar Kalathil, Country General Manager for Agilent India in detail. Edited excerpts:
4 min |
December 2025
Bio Spectrum
Supporting India's Biopharma Expansion with Advanced, High-Performance Media
Kent Wang graduated from East China University of Science and Technology in Biochemical Engineering. He has over 12 years of experience in upstream biopharmaceutical process development, contributing to clinical projects including monoclonal antibodies, bispecific antibodies, and ADCs. He is well-versed in CHO cell metabolism and culture media characteristics, and has optimized critical quality attributes such as glycosylation, charge variants, fragmentation, aggregation, and amino acid oxidation. Previously at Shanghai Pharmaceuticals Group and 3S Bio, he now serves as Senior R&D Director at Duoning Biotech, focusing on serum-free cell culture media development. He established a comprehensive platform for media formulation and product development, leading his team to create a diverse portfolio of media for CHO, HEK293, insect, vaccine, hybridoma, and lymphocyte cell lines, leveraging cell metabolism insights and big data modeling.
4 min |
December 2025
Bio Spectrum
Corning and SGD Pharma inaugurate glass tubing facility in Telangana for pharma packaging
Corning Inc and SGD Pharma have announced the inauguration of a new glass tubing facility in Telangana, which will expand pharmaceutical manufacturing in the region.
1 min |
December 2025
Bio Spectrum
BTS 2025 Solidifies Karnataka's Global Tech Leadership
The 28th edition of the Bengaluru Tech Summit (BTS) 2025 concluded on November 20 at the Bangalore International Exhibition Centre (BIEC), wrapping up three days of high-impact innovation, global collaboration, and technology leadership.
3 min |
December 2025
Bio Spectrum
VFL Sciences launches lab photobioreactors GreatFlo PBR
Chennai-based VFL Sciences has announced the launch of GreatFlo PBR, laboratory Photo Bioreactors during the IKMC 2025 exhibition at Hyderabad. VFL Sciences Photo Bioreactors have been designed with focus on customers to deliver a state-of-the-art instrument that fits comfortably on a lab bench.
1 min |
December 2025
Bio Spectrum
Aber and Sartorius unveil BioPAT Viamass single-use biomass sensors
Aber Instruments and Sartorius Stedim Biotech have announced the introduction of the BioPAT Viamass single-use biomass sensor now fully integrated into Ambr 250 High Throughput single-use bioreactor vessels.
1 min |
December 2025
Bio Spectrum
Remidio unveils breakthrough in AI-enabled.retinal imaging for newborns
Bengaluru-based Remidio Innovative Solutions, a leader in artificial intelligence (AI)-powered ophthalmic devices, has announced the launch of Neubo 130, a next-generation ultra-widefield neonatal retinal imaging system designed to enhance precision diagnostics for neonatal retinal conditions like Retinopathy of Prematurity (ROP).
1 min |
December 2025
Bio Spectrum
How AI is Redefining Talent and Innovation in Life Sciences
AI's future in life sciences will be driven by hybrid expertise, continuous upskilling, and strong collaboration across academia, industry, and clinical practice to build a smarter, more responsive healthcare ecosystem.
5 min |
December 2025
Bio Spectrum
Converging MedTech with Affordability in 2026
On October 25, the Anusandhan National Research Foundation (ANRF) launched the Mission for Advancement in High-Impact Areas (MAHA)-Medical Technology, in collaboration with the Indian Council of Medical Research (ICMR) and the Gates Foundation. With an objective to accelerate innovation in India's medical technology sector, reduce reliance on high-cost imports, and promote equitable access to affordable and high-quality medical technologies, new doors are opening up for the MedTech sector in 2026, with greater emphasis on startups. Let's take a close look at how the MedTech startups are redefining India's innovation ecosystem.
4 min |
December 2025
Bio Spectrum
Biocon Biologics and Civica expand partnership to launch private-label insulin glargine in US
Bengaluru-based Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced expansion of its strategic collaboration with Civica, Inc. to include a new Insulin Glargine medicine that will benefit patients in the United States by increasing supply of high-quality affordable insulins.
1 min |
December 2025
Bio Spectrum
C-CAMP signs MoU with NIMHANS to launch Centre for Bioentrepreneurship in Neurosciences and Mental Health
Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) and the National Institute of Mental Health and Neurosciences (NIMHANS), an institute of national importance, and the India’s largest public sector research organisation in mental health and neuroscience, have joined hands to set up a unique initiative – the Centre for Bioentrepreneurship in Neurosciences and Mental Health.
1 min |
December 2025
Bio Spectrum
TRENDS 2026: Rise of RESILIENT Life Sciences Innovation
US President Donald Trump's tariffs, with a fear of global recession and geopolitical tensions affecting industries worldwide, was the memorable aspect of 2025. Despite these challenges, the Indian life sciences sector has remained resilient and steadfast. To avoid the impact of Trump's tariffs, almost all major pharma firms expanded or increased their presence in the US, often through acquisitions. A key highlight was the Indian government introducing several measures to simplify drug approvals and support innovation. Key reforms included updating the New Drug and Clinical Trial Rules (2019) and adopting digital platforms for regulatory submissions to improve transparency, reduce approval timelines, strengthen pharmacovigilance, and maintain quality standards. As we move into 2026, many of the trends and themes from 2025 are expected to carry forward, shaping the industry's trajectory in the year ahead. Let's look at these trends across different sectors.
9 min |
December 2025
Bio Spectrum
Ayush Ministry announces SPARK-4.0 to nurture young ayurveda researchers
The Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush, has announced SPARK-4.0 (2025-26)—the fourth edition of its flagship Studentship Programme for Ayurveda Research Ken (SPARK).
1 min |
December 2025
Bio Spectrum
Bharat Biotech launches Nucelion, CRDMO arm to focus on next-gen cell and gene therapy
Bharat Biotech International Ltd, announced the launch of Nucelion Therapeutics, a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies as its wholly owned subsidiary in Hyderabad.
1 min |
December 2025
Bio Spectrum
Philips and Nicolab collaborate to advance stroke care in India
Dutch firm Philips is expanding its collaboration with Nicolab, The Netherlands-based company pioneering in artificial intelligence (AI)-powered stroke care, to advance stroke care in India.
1 min |
December 2025
Bio Spectrum
Veteran policy maker & former IRDAI Chairman Debasish Panda joins Pristyn Care
Debasish Panda, former Chairman of the Insurance Regulatory and Development Authority of India (IRDAI) has taken on the role of Senior Advisor to Pristyn Care.
1 min |
December 2025
Bio Spectrum
Shilpa Medicare opens flow chemistry manufacturing centre in Bengaluru
Shilpa Medicare, a full-service contract development and manufacturing organisation (CDMO), has announced the launch of its new flow chemistry Centre of Excellence (CoE).
1 min |
December 2025
Bio Spectrum
AI Becomes Pharma's Powerhouse in 2025
As we wrap up 2025, we take a close look at the major developments that took place across the globe, including India, within the artificial intelligence (AI)-driven drug discovery segment. Highlighting one of the most recent announcements, US-based pharma major Eli Lilly has partnered with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery.
2 min |
December 2025
Bio Spectrum
Sanofi India appoints Deepak Arora as new Managing Director
Pharma major Sanofi India has appointed Deepak Arora as the company's Managing Director with effect from October 27, 2025. In this role, Arora will define and drive the strategic vision for India in alignment with Sanofi's global strategy.
1 min |
December 2025
Bio Spectrum
DPIIT signs MoU with Primus Partners to strengthen startup ecosystem
The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MOU) with Primus Partners to enhance collaboration towards strengthening India's startup and innovation ecosystem.
1 min |
December 2025
Bio Spectrum
"India can become a global hub for AI-driven diagnostics if right policy environment is in place"
With India emerging as the fourth largest medical devices market in Asia after Japan, China, and South Korea, the Indian medical technology sector is being recognised as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities. The size of the Indian medical devices sector is estimated to be around $14 billion and it is expected to grow to $30 billion by 2030 where artificial intelligence (AI) is bound to play a major role. Amidst this scenario, Japan's medtech player Fujifilm is uniquely positioning it's presence to meet India's growing healthcare demands, blending AI, advanced imaging, and affordable solutions. In an exclusive interaction with BioSpectrum Asia, Koji Wada, Managing Director (Healthcare Division), Fujifilm India spoke about the company's expansion plans in India.
4 min |
December 2025
Bio Spectrum
Plasmagen Biosciences onboards Vivek V Kamath as Chief Executive Officer
Bengaluru-based Plasmagen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, has announced the appointment of Vivek V Kamath as its Chief Executive Officer. Kamath brings over three decades of leadership experience in healthcare, spanning pharmaceuticals, over-the-counter (OTC) products and diagnostics.
1 min |
December 2025
Bio Spectrum
Telangana targets Rs 1 lakh crore investments in Life Sciences by 2030
Telangana has set an ambitious target of attracting Rs 1 lakh crore in new investments in the Life Sciences sector by 2030, aiming to generate employment for five lakh people, as per Minister for IT and Industries Duddilla Sridhar Babu.
1 min |
December 2025
Bio Spectrum
'Despite global funding slowdowns, India's early-stage healthcare scene, especially in digital health and diagnostics, remains strong'
US-based Illumina Inc., a global leader in DNA sequencing and array-based technologies, established its presence in India nearly 20 years ago, laying the foundation for a strong role in the country's genomics ecosystem. At present, Illumina is driving early cancer detection in India by advancing comprehensive genomic profiling and enabling liquid biopsy technologies. With new expansion plans in place, Illumina is all set to further strengthen India's genomics landscape. In an exclusive interaction with BioSpectrum India, Suchita Dayanand, Country Head – India (Commercial), Illumina shares her plans. Edited excerpts;
4 min |
December 2025
Bio Spectrum
Siegwerk makes entry into pharma packaging segment in India with Rs 350 Cr investment
German firm Siegwerk has announced its strategic entry into the pharmaceutical packaging segment in India, reinforcing its commitment to consumer safety.
1 min |
December 2025
Bio Spectrum
Karnataka unveils Rs 600+ Cr 'Deep Tech Decade' initiative
The Government of Karnataka has announced an investment of over Rs 600 crore to power the state's \"Deep Tech Decade,\" with the goal of establishing Karnataka as the Deep Tech Capital of India.
1 min |
December 2025
Bio Spectrum
Revvity and Profluent bring AI-enhanced adenine deaminase pin-point base editing systems
US-based Revvity, Inc. has announced a strategic collaboration with Profluent, also based in the US, bringing together a range of its novel artificial intelligence (AI)engineered enzymes with Revvity's established Pin-point base editing platform.
1 min |
December 2025
Bio Spectrum
Agilent introduces Altura Line of Inert HPLC columns for biotherapeutic testing
Agilent Technologies Inc. has announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications.
1 min |
December 2025
Bio Spectrum
Bartronics India makes strategic investment of up to Rs 50 Cr in Huwel Life Sciences
Hyderabad-based Bartronics India Limited (BIL), a listed technology and services company, has announced a strategic investment of up to Rs 50 crore in Huwel Life Sciences, a molecular diagnostics startup, also based in Hyderabad.
1 min |